In preclinical studies of CSU, Bexobrutideg demonstrates potent BTK degradation across key immune cell types and enhanced suppression of ...

Interim analysis demonstrated a 55.0% relative reduction in proteinuria versus placebo at 39 weeks with eGFR remaining stable through treatment ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) ("Dogwood” or the "Company”), a company that focuses on developing first-in-class, ...

Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026 - - FDA acceptance of SP16 Investigational New Drug Application for the treatment of Chemotherapy ...

Nearly five years after returning to power, the Taliban are no longer merely an insurgent movement that seized control of a fractured state .

I want to start with a question we’ve all been asked a thousand times—in grocery stores, in elevators, in the opening minutes ...

In Family Violence Appellate Project v. Superior Court, the justices will consider whether a statutory ban on widespread use ...

From April 24 through April 26, memories were shared and new memories made, as Reunion 2026 brought together members of the ...

Pomdoctor Limited ("Pomdoctor" or the "Company") , a leading online medical services platform for chronic diseases in China, today announced its financial results for the fiscal year ended December 31 ...

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing treatments for serious, ...